Dapsone Gel — FDA Drug Shortage

To Be Discontinued — Amneal Pharmaceuticals

The FDA lists a drug shortage record for Dapsone Gel (gel) from Amneal Pharmaceuticals with status To Be Discontinued. The shortage was first posted on Mar 27, 2026.

Shortage details

Status
To Be Discontinued
Company
Amneal Pharmaceuticals
Package NDC
69238-1627-6
Dosage Form
Gel
Presentation
Dapsone, Gel, 7.5% (NDC 69238-1627-6)
Initial Posting
Mar 27, 2026

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.